EconomyBig Pharma Is Hooked on Chinese Licensing Deals

Expanding partnerships between US drugmakers and Chinese companies offer lower costs and greater access to breakthrough treatments. Critics in Washington, however, see the deals as a source of risk.

pharmaceuticalsChinalicensing deals

BBloomberg News★★★☆☆2026-08-19 07:30Original